Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron.

Emerging microbes & infections - 1 Dec 2022

Zhang Li, Li Qianqian, Liang Ziteng, Li Tao, Liu Shuo, Cui Qianqian, Nie Jianhui, Wu Qian, Qu Xiaowang, Huang Weijin, Wang Youchun

Abstract excerpt

The emergence of Omicron/BA.1 has brought new challenges to fight against SARS-CoV-2. A large number of mutations in the Spike protein suggest that its susceptibility to immune protection elicited by the existing COVID-19 infection and vaccines may be altered. In this study, we constructed the pseudotyped SARS-CoV-2 variant Omicron. The sensitivity of 28 serum samples from COVID-19 convalescent patients infected...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacillus and Francisella bacterial research
Share to COVID-19

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Host-Pathogen Interactions

Share to Immune Evasion

Share to Mutation

Share to SARS-CoV-2

Share to SARS-CoV-2 and COVID-19 Research

Share to Spike Glycoprotein, Coronavirus

Source

Open in PubMed Open full text

Identifiers

PMID: 34890524
DOI: 10.1080/22221751.2021.2017757
PMCID: PMC8725892

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron.PMID 34890524Read ↗

Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinationsSemantic proximity Read ↗

SARS-CoV-2 Omicron variant escapes neutralization by vaccinated and convalescent sera and therapeutic monoclonal antibodiesSemantic proximity Read ↗

Evaluation of immune evasion in SARS-CoV-2 Delta and Omicron variantsSemantic proximity Read ↗

Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 VariantsSemantic proximity Read ↗

Mutations in the spike RBD of SARS-CoV-2 omicron variant may increase infectivity without dramatically altering the efficacy of current multi-dosage vaccinationsSemantic proximity Read ↗

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathwaySemantic proximity Read ↗

SARS‐CoV‐2 Omicron variant: Immune escape and vaccine developmentSemantic proximity Read ↗

Increased resistance of SARS-CoV-2 Omicron Variant to Neutralization by Vaccine-Elicited and Therapeutic AntibodiesSemantic proximity Read ↗

An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivoSemantic proximity Read ↗

Impact of Mutations Defining SARS-CoV-2 Omicron Subvariants BA.2.12.1 and BA.4/5 on Spike Function and NeutralizationSemantic proximity Read ↗

Impact of mutations defining SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 on Spike function and neutralizationSemantic proximity Read ↗

SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine boosterSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.